pembrolizumab
Mon, 28 Mar 2022 15:31:07 -0400
Pembrolizumab is indicated for the adjuvant treatment of adult and pediatric (12 years and older) patients with Stage IIB or IIC melanoma following complete resection.
Mon, 28 Mar 2022 15:31:07 -0400
Pembrolizumab is indicated for the adjuvant treatment of adult and pediatric (12 years and older) patients with Stage IIB or IIC melanoma following complete resection.
80.211.154.110